nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP

First Page		Document Content
$Eli Lilly and Company / Osteopathies / Osteoporosis / Bone density / FRAX / Dual-energy X-ray absorptiometry / Strontium ranelate / Denosumab / Hip fracture / Medicine / Bisphosphonates / Drugs$ Date: 2014-03-21 08:30:50 Eli Lilly and Company Osteopathies Osteoporosis Bone density FRAX Dual-energy X-ray absorptiometry Strontium ranelate Denosumab Hip fracture Medicine Bisphosphonates Drugs		nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Add to Reading List Source URL: www.shef.ac.uk Download Document from Source Website File Size: 389,39 KB Share Document on Facebook

	Analysis of risk factors of hip fracture with causal Bayesian networks Alex Aussem1 , Pascal Caillet2 , Zara Klemm1 , Maxime Gasse1 , Anne-Marie Schott2 , and Michel Ducher3 1 DocID: 1uKDV - View Document
	IMPORTANT: PLEASE READ activity, such as lifting, or from minor injury that would not ordinarily fracture normal bone. Fractures usually occur at the hip, spine, or wrist and can lead not only to pain, but also to con DocID: 1uFBR - View Document
	Master’s Thesis Proposal Multiaxial yield behavior of human trabecular bone Background Hip fracture is a major medical problem among osteoporotic patients. Finite element (FE) analysis can improve fracture risk predic DocID: 1u5Br - View Document
$Medicine / Bone fractures / Clinical medicine / Health / Tibial plateau fracture / Bisphosphonate / Osteoporosis / Femoral fracture / Alendronic acid / Orthopedic surgery / Hip / Bone$	www.edoriumjournals.com CASE SERIES PEER REVIEWED \| OPEN ACCESS DocID: 1rkMG - View Document
$Medicine / Clinical medicine / Anatomy / Bone fractures / Osteopathies / RTT / Osteoporosis / Hip fracture / Dual-energy X-ray absorptiometry / Bone density / Bone / Osteopenia$	Bo n e an d m in eral Prevalence 10 DocID: 1r6Qq - View Document